April 16th, 2013
Alemu. A., S., Kempker. R., R., Tenna. A., et al.
Andama. A., O., S. den Boon. S. et al.
Meyer. A. -C., Kendi. C., K. et al.
January 25th, 2013
McMullan BJ, Halliday C, Sorrell TC, et al.
Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory
Binnicker MJ, Jespersen DJ, Bestrom JE, Rollins LO.
Comparison of four assays for the detection of cryptococcal antigen
Hansen J, Slechta ES, Gates-Hollingsworth MA, et al.
___________________________________________________________
December 20th, 2012
New Southern African Society Cryptococcal Treatment Guidelines
Cryptococcal Screening Algorithm (December 2012)
African Society for Laboratory Medicine
Meya, D., Boulware,D. (2012 ). Cryptococcal Antigen Screening: Perspectives from Uganda
Govender, N.,P (2012). Cryptococcosis: Preventing a Deadly Fungal Disease Together.
Bauman, (2012) A Simple Method to Diagnose Cryptococcosis: CrAg LFA.
Graeme, M. ( 2012). Treatment of Cryptococcal Meningitis
_______________________________________________________________
December 8th, 2012
Govender, N., P., et al. South Africa Medical Journal Editorial, Dec. 2012.
Phased Implementation of Screening for Cryptococcal Disease in South Africa
National Institute for Communicable Diseases -Monthly Surveillance Report
Laboratory Based Screening for Cryptococcal Diseases
South African National Institute for Communicable Diseases -NHLS Communiqué November 2012
_______________________________________________________________
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with CD4<100 cells/mcL
WHO Guidelines – 2011
Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children
(2011, PDF, 0.539 MB) Read the WHO’s late-breaking recommendations on diagnosis, prevention and management of cryptococcal disease, including the utility of screening and pre-emptive therapy to reduce mortality caused by cryptococcosis.
